What is the treatment for Pterygium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pterygium

Surgery is the definitive treatment for pterygium when it causes visual impairment, significant astigmatism, threatens the optical axis, or causes persistent ocular surface discomfort. 1, 2, 3

Indications for Surgical Intervention

Surgical removal is indicated when pterygium causes: 3, 4

  • Loss of visual acuity from encroachment on the visual axis
  • Increasing corneal astigmatism affecting vision quality
  • Impending invasion of the optical axis (even before visual symptoms)
  • Persistent ocular surface discomfort unresponsive to conservative measures

Optimal Surgical Technique

The bare sclera excision technique alone is no longer acceptable due to unacceptably high recurrence rates. 1, 5 Modern pterygium surgery must combine excision with adjunctive measures to prevent recurrence.

Recommended Surgical Approaches:

Conjunctival autografting is the most commonly used and effective method for preventing recurrences. 1, 2 The surgical options in order of preference include:

  • Limbal conjunctival autograft - preferred technique 2
  • Free conjunctival autograft - highly effective alternative 2, 4
  • Amniotic membrane transplantation - when autograft unavailable 2, 3
  • Rotational conjunctival flap - alternative coverage method 2
  • Peripheral lamellar keratoplasty - reserved for cases with significant corneal ingrowth 3

Adjunctive Anti-Recurrence Therapy

Mitomycin C at 0.02% concentration (0.2 mg/ml) applied for brief periods (e.g., 15 seconds) during surgery effectively prevents recurrence. 6 However, use it judiciously due to potential sight-threatening complications with long-term exposure. 1

Additional adjunctive options include: 2, 3

  • 5-fluorouracil - alternative antimetabolite
  • Beta-radiation - use with extreme caution due to long-term complication risks 1
  • Topical interferons - emerging option
  • Anti-VEGF agents (Avastin) - novel anti-angiogenic approach 2, 4

Critical Caveat on Antimetabolites:

Both mitomycin C and beta-irradiation carry risks of serious long-term sight-threatening complications and should be used judiciously. 1 The decision to use these agents must weigh recurrence risk against complication potential.

Anesthetic Considerations

Use topical anesthesia rather than retrobulbar anesthesia to reduce the risk of postoperative diplopia. 6 Retrobulbar blocks increase diplopia risk compared to topical techniques. 7

Postoperative Management

Following pterygium surgery, implement this regimen: 8, 4

  • Topical steroid-antibiotic combination (e.g., Tobradex) for 1-2 weeks to prevent infection and control inflammation 8
  • Preservative-free lubricants for long-term ocular surface comfort 4
  • Monitor intraocular pressure if using steroids, especially in glaucoma patients 8
  • Limit steroid duration to minimize complications including elevated IOP, cataract formation, and delayed wound healing 8

Important Warning:

Prolonged topical antibiotic use promotes resistant organism growth; limit duration appropriately. 8

Potential Surgical Complications

Be aware of these specific complications: 7, 6

  • Diplopia from medial rectus muscle damage or scarring - most common motility complication
  • Exotropia from direct medial rectus damage during excision
  • Esotropic restrictive strabismus from excessive scarring
  • Ocular motility problems from florid scarring with recurrence

Careful surgical technique minimizing medial rectus manipulation is essential to prevent these complications. 6

Long-Term Prevention Strategy

After successful surgery, patients require: 4

  • Long-term UV protection with wraparound sunglasses - addresses primary etiology
  • Regular follow-up to detect early recurrence
  • Continued preservative-free lubrication for ocular surface health

Conservative Management (Non-Surgical)

For early, asymptomatic pterygium not meeting surgical criteria: 3

  • Observation with UV protection
  • Preservative-free artificial tears for dry eye symptoms (burning, itching, tearing)
  • Topical lubricants for ocular surface discomfort

However, once visual symptoms or significant growth occurs, delaying surgery risks more aggressive recurrence requiring repeated interventions. 3

References

Research

Current concepts and techniques in pterygium treatment.

Current opinion in ophthalmology, 2007

Research

Update on overview of pterygium and its surgical management.

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2022

Research

[Pterygium: etiology, pathogenesis, treatment].

Vestnik oftalmologii, 2017

Research

[Pterygium. Etiology, clinical aspects and novel adjuvant therapies].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2010

Research

The treatment of pterygium.

Survey of ophthalmology, 2003

Guideline

Treatment of Pterygium with Adjunctive Therapies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Surgical Treatment of Pterygium

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Post-Pterygium Surgery Management with Tobradex

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.